August 10, 2026 06:09 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jharkhand student protest turns tense: Water cannons, lathicharge after Assembly march barricades breached | ‘Mother tongue is as pure as one's mother’: Vijay-led Tamil Nadu government makes Tamil Thaai Vazhthu mandatory in big language push | Indian envoy Kwatra cites US, UK laws to counter ‘myths’ around FCRA Bill | Jharkhand students march to assembly today: JPSC row escalates despite govt action | ‘A morning I will cherish’: Raghav Chadha meets PM Modi, shares photos from ‘enriching’ meeting | Delhi Mercedes crash kills 70-year-old woman: Cop’s son behind wheel, beer bottle found | Indian-origin woman accused of ‘visa fraud’ on X: US Attorney steps in with major clarification | US Senate passes Russia sanctions bill: India can face Trump’s 100% tariff threat | Expired meat, rotten vegetables found at Bengaluru's luxury hotels, legal action begins | 'I'm ready to be humiliated': Vijay, Udhayanidhi Stalin clash in Tamil Nadu Assembly over Cauvery dispute
Omicron
Unsplash

Omicron strain found in 63 countries, might surpass Delta in spreading speed: WHO

| @indiablooms | Dec 13, 2021, at 04:00 am

Geneva/UNI/Sputnik: The new Omicron coronavirus strain was found in 63 countries and, according to preliminary data, it will exceed Delta's spreading speed in the world, the World Health Organization (WHO) said.

"As of 9 December 2021, cases of human infections with this variant have been identified in 63 countries across all six WHO regions," the overview by the WHO read.

It is not clear yet, why the new strain is spreading so fast, the organization added.

"However, given the current available data, it is likely that Omicron will outpace the Delta variant where community transmission occurs," the document said.

The Omicron variant might reduce the effectiveness of COVID-19 vaccines based on preliminary data, but this strain is less dangerous than Delta, the organization assumed.

"There are limited available data, and no peer-reviewed evidence, on vaccine efficacy or effectiveness to date for Omicron. Preliminary evidence, and the considerably altered antigenic profile of the Omicron spike protein, suggests a reduction in vaccine efficacy against infection and transmission associated with Omicron," the statement said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.